Aleksandra Filipovic

Aleksandra Filipovic

Company: PureTech Health

Job title: Head of Oncology


Aleksandra Filipovic is the Head of Oncology at PureTech. Previously, she was associate medical director, oncology and immuno-oncology, at Bristol Myers Squibb. Dr Filipovic graduated from the Faculty of Medicine University of Nis, Serbia, and did her PhD on identification and validation of therapeutic targets in breast cancer and monoclonal antibody drug development at Imperial College London, UK, followed by a Clinical Research Fellowship to continue research and clinical work in medical oncology. She is a clinician at Imperial College NHS trust, European School of Oncology faculty member, Member of the Scientific Board of Sharing progress in Cancer Care (SPCC), associate editor for Frontiers in Oncology and member of ASCO, ESMO, AACR and SITC.


Live Q&A Discussion 12:20 pm

Read more

day: Day One

Novel Immunotherapy Specific for & Effective Against Immunosuppressive γδ1 T Cells 11:40 am

• γδ1 T cells possess a pro-tumorigenic capacity and are enriched in tumors such as pancretic ductal adenocarcinoma (PDA), glioblastoma, breast cancer, cholangiocarcinoma, colorectal cancer and melanoma – where they can confer resistance to checkpoint inhibitors • We have used phage display-based selection to generate a novel, fully human IgG1 antibody, specific to both human…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.